GSK Pharma Q3 net drops 7.6%

GSK Pharma Q3 net drops 7.6%

Mumbai: GlaxoSmithKline Pharmaceuticals Ltd, Indian unit of British drug maker GSK Plc, has posted 7.6% drop in net profit at 145.86 crore in the quarter ended 30 September as against 157 crore a year ago. Its sales grew 4.47% to 607.56 crore.

The company’s vaccine and specialty segments continue to register strong double digit growth which includes dermatology, oncology, cardiovascular and metabolic disorders, he added.

GSK shares moved up 0.98% to close at 2109.55 on Bombay Stock Exchange on Friday.

Close